Homebiotech

biotech

Merck’s Combination Therapy Fails Phase III Lung Cancer Study

Merck’s Combination Therapy Fails Phase III Lung Cancer Study

March 22, 2024

Lilly Teams Up with Amazon to Deliver Drugs Such as Zepbound

Lilly Teams Up with Amazon to Deliver Drugs Such as Zepbound

March 14, 2024

Moderna Stock Surges 9% as Neoantigen Therapy’s Phase II/III Study Progresses

Moderna Stock Surges 9% as Neoantigen Therapy’s Phase II/III Study Progresses

March 12, 2024

Thermo Fisher Introduces CorEvitas Clinical Registry

Thermo Fisher Introduces CorEvitas Clinical Registry

March 11, 2024

JNJ Receives Full FDA Approval for Rybrevant in Lung Cancer Treatment

JNJ Receives Full FDA Approval for Rybrevant in Lung Cancer Treatment

March 4, 2024

Moderna Exceeds Expectations in Q4 Earnings and Revenue, Maintains Outlook

Moderna Exceeds Expectations in Q4 Earnings and Revenue, Maintains Outlook

February 22, 2024

BioLineRx Class Action Alert: Submit Your Losses to Johnson Fistel

BioLineRx Class Action Alert: Submit Your Losses to Johnson Fistel

January 5, 2023

Cyclacel Pharmaceuticals Reviews 2022 Achievements and Announces Key Business Objectives for 2023

Cyclacel Pharmaceuticals Reviews 2022 Achievements and Announces Key Business Objectives for 2023

January 5, 2023

CNS Pharmaceuticals to Present at the Virtual Investor 2023 Companies to Watch Event

CNS Pharmaceuticals to Present at the Virtual Investor 2023 Companies to Watch Event

January 5, 2023

Acasti to Host Conference Call on Tuesday, January 10, 2023 to Discuss Results from Recent Phase 1 PK Studies for GTX-101 and GTX-102 That Met All Outcome Measures

Acasti to Host Conference Call on Tuesday, January 10, 2023 to Discuss Results from Recent Phase 1 PK Studies for GTX-101 and GTX-102 That Met All Outcome Measures

January 5, 2023

1 2 3 … 558 »